Search - tctmd.com

Displaying 1 - 20 of 143

Sort: Relevancy | Date

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

Podcast Heart Sounds

Most Memorable Stories of 2024

December 25, 2024

News Daily News

Radial Artery Best for Secondary Access During TAVI: PULSE Registry

Michael O'Riordan

December 23, 2024

News Daily News

PREDIMED Analysis May Rekindle Hope for Wine’s Heart Benefits

Michael O'Riordan

December 18, 2024

News Daily News

Editor’s Pick: TCTMD’s Best Long Reads of 2024

Shelley Wood

December 17, 2024

News Daily News

Sudden Cardiac Death in Athletes Is Rare, but Affects Black Population More

Michael O'Riordan

December 06, 2024

Sustained Benefit With Pascal TEER Device at 2 Years: CLASP IID and MiCLASP

Michael O'Riordan

December 05, 2024

News Daily News

Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 Top-line Results

Michael O'Riordan

December 04, 2024

News Conference News PCR London Valves 2024

Reverse Remodeling and Higher Stroke Volume With TEER: TRILUMINATE

Michael O'Riordan

December 03, 2024

News Conference News PCR London Valves 2024

Electrical Variables, Not Valve Type, Predict Need for Pacemaker After TAVI

Michael O'Riordan

December 02, 2024

News Conference News PCR London Valves 2024

Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years

Michael O'Riordan

November 27, 2024

News Conference News PCR London Valves 2024

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

Michael O'Riordan

November 26, 2024

News Conference News PCR London Valves 2024

Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia

Michael O'Riordan

November 26, 2024

News Conference News PCR London Valves 2024

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Michael O'Riordan

November 25, 2024

News Conference News AHA 2024

ZODIAC: Decision-Support Tool Doesn’t Sway Lipid-Lowering Treatments in ACS

Michael O'Riordan

November 21, 2024

News Conference News AHA 2024

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

Michael O'Riordan

November 18, 2024

News Conference News AHA 2024

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

Michael O'Riordan

November 17, 2024

News Conference News AHA 2024

Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F

Michael O'Riordan

November 16, 2024

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

News Conference News AHA 2024

US Obesity Epidemic Continues to Skyrocket, With No End in Sight

Michael O'Riordan

November 15, 2024

Advertisement

Top Coronary Artery Disease News in 2024

Most Memorable Stories of 2024

Radial Artery Best for Secondary Access During TAVI: PULSE Registry

PREDIMED Analysis May Rekindle Hope for Wine’s Heart Benefits

Editor’s Pick: TCTMD’s Best Long Reads of 2024

Sudden Cardiac Death in Athletes Is Rare, but Affects Black Population More

Sustained Benefit With Pascal TEER Device at 2 Years: CLASP IID and MiCLASP

Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 Top-line Results

Reverse Remodeling and Higher Stroke Volume With TEER: TRILUMINATE

Electrical Variables, Not Valve Type, Predict Need for Pacemaker After TAVI

Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

ZODIAC: Decision-Support Tool Doesn’t Sway Lipid-Lowering Treatments in ACS

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

US Obesity Epidemic Continues to Skyrocket, With No End in Sight

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content